Heart composed of blood cells, with an ECG rhythm strip symbolizing predictive cardiology.

Decoding Atrial Fibrillation: Can a Simple Blood Test Predict Your Risk?

Theo Raines in Health & Wellness July 2025 • 3 min read.

"New research reveals how complete blood count (CBC) tests can be used to predict new-onset and recurrent atrial fibrillation, offering a non-invasive way to assess your heart health."

Atrial fibrillation (AFib) affects millions worldwide and is a leading cause of stroke, heart failure, and diminished quality of life. Managing and predicting AFib is a major challenge in cardiovascular health. Traditionally, doctors rely on medical history, physical exams, and cardiac monitoring to diagnose and manage AFib. However, recent research suggests that a routine blood test, the complete blood count (CBC), could provide valuable insights into AFib risk.

A new meta-analysis published in "Med Sci Monit Basic Res" has explored the potential of CBC tests to predict both new-onset and recurrent AFib. This comprehensive review examines numerous studies, pooling data to assess the strength of the association between hematological parameters and AFib.

The study offers a fresh perspective on utilizing commonly available data to improve AFib risk assessment. By understanding the predictive power of CBC tests, healthcare providers may be able to identify high-risk individuals and implement preventive strategies earlier, potentially reducing the burden of this prevalent arrhythmia.

CBC Tests: A New Window into Atrial Fibrillation?

Heart composed of blood cells, with an ECG rhythm strip symbolizing predictive cardiology.

The study analyzed data from numerous observational studies, evaluating hematological parameters in patients with both new-onset and recurrent AFib. Researchers conducted a thorough search of major databases, screening thousands of studies to identify those that met specific inclusion criteria. The meta-analysis ultimately included 70 studies on new-onset AFib and 23 studies on recurrent AFib.

The researchers extracted and analyzed a range of hematological parameters obtained from CBC tests, including:

Platelet count (PC)
Mean platelet volume (MPV)
White blood cell count (WBC)
Neutrophil-to-lymphocyte ratio (NLR)
Red blood cell distribution width (RDW)

By pooling data from multiple studies, the meta-analysis aimed to provide a more robust and reliable estimate of the association between these parameters and AFib than any single study could achieve.

CBC: A Simple Test, Powerful Insights

This study highlights the potential of complete blood count tests as a predictive tool for atrial fibrillation. Hematological parameters have significant ability to predict occurrence and recurrence of AF. Emphasizing the potential predictive role of hematological parameters for new-onset and recurrent AF, we recommend adding the CBC test to the diagnostic modalities of AF in clinical practice.

About this Article -

This article was crafted using a human-AI hybrid and collaborative approach. AI assisted our team with initial drafting, research insights, identifying key questions, and image generation. Our human editors guided topic selection, defined the angle, structured the content, ensured factual accuracy and relevance, refined the tone, and conducted thorough editing to deliver helpful, high-quality information.See our About page for more information.

Everything You Need To Know

What is atrial fibrillation (AFib), and why is it a significant health concern?

Atrial fibrillation (AFib) is a common heart condition where the upper chambers of the heart beat irregularly and often rapidly. This irregular rhythm can lead to serious complications, including stroke, heart failure, and a diminished quality of life. The significant health concern stems from AFib's ability to disrupt normal blood flow, potentially causing blood clots that can travel to the brain and other organs. Managing and predicting AFib is crucial in cardiovascular health because early detection and intervention can significantly reduce the risk of these life-threatening events.

How can a complete blood count (CBC) test help in understanding my risk of atrial fibrillation (AFib)?

A complete blood count (CBC) test, a routine blood test, can provide valuable insights into your risk of developing or experiencing recurrent atrial fibrillation (AFib). The study published in "Med Sci Monit Basic Res" indicates that certain hematological parameters derived from the CBC test, such as platelet count (PC), mean platelet volume (MPV), white blood cell count (WBC), neutrophil-to-lymphocyte ratio (NLR), and red blood cell distribution width (RDW), can predict both new-onset and recurrent AFib. By analyzing these parameters, healthcare providers can potentially identify high-risk individuals and implement preventive strategies.

What specific hematological parameters from a CBC test are used to assess the risk of atrial fibrillation (AFib)?

The study analyzed several hematological parameters obtained from CBC tests to assess the risk of atrial fibrillation (AFib). These parameters include platelet count (PC), which reflects the number of platelets in your blood; mean platelet volume (MPV), which indicates the average size of your platelets; white blood cell count (WBC), which reflects the number of white blood cells; neutrophil-to-lymphocyte ratio (NLR), which is calculated from the counts of neutrophils and lymphocytes; and red blood cell distribution width (RDW), which measures the variation in the size of red blood cells. Each of these parameters provides different information about your blood's composition and can be used in conjunction with other factors to predict your risk.

How was the research conducted to determine the relationship between CBC test results and atrial fibrillation (AFib)?

The research was conducted using a meta-analysis approach, which is a comprehensive review of existing studies. Researchers searched major databases for observational studies that included data on CBC test results and atrial fibrillation (AFib) outcomes. They screened thousands of studies, ultimately including 70 studies on new-onset AFib and 23 studies on recurrent AFib. The researchers extracted and analyzed hematological parameters, including platelet count (PC), mean platelet volume (MPV), white blood cell count (WBC), neutrophil-to-lymphocyte ratio (NLR), and red blood cell distribution width (RDW). By pooling the data from multiple studies, they aimed to achieve a more robust and reliable estimate of the association between these parameters and AFib than any single study could achieve.

Why is it beneficial to include the complete blood count (CBC) test in the diagnosis of atrial fibrillation (AFib)?

Including the complete blood count (CBC) test in the diagnosis of atrial fibrillation (AFib) offers several benefits. The CBC test provides a non-invasive way to assess the risk of developing or experiencing recurrent AFib. The study highlights the predictive role of hematological parameters for new-onset and recurrent AF. By incorporating the CBC test into diagnostic modalities, healthcare providers can potentially identify individuals at higher risk earlier. This early identification allows for the implementation of preventive strategies, such as lifestyle changes and medication, which could reduce the burden of AFib and its associated complications like stroke and heart failure.